Advertisement
Document › Details
Hyloris Pharmaceuticals S.A.. (6/3/20). "Press Release: Hyloris Pharmaceuticals Announces Intention to Launch an Initial Public Offering on Euronext Brussels [Not for US, AU, CA, CH, IL, JP or ZA]". Liège.
Original document
accessed by [iito] on 2020-06-17
Record changed: 2023-06-05 |
Advertisement
More documents for Hyloris Pharmaceuticals S.A.
- [1] Pleco Therapeutics B.V.. (9/6/22). "Press Release: Pleco Therapeutics Announces Final Close of Its Series A Financing Raising €17.3m to Progress its Novel Plecoid Product in Acute Myeloid Leukaemia to Regulatory Filing in USA and EU". Nijmegen....
- [2] Hyloris Pharmaceuticals S.A.. (2/3/21). "Press Release: Hyloris Appoints Marieke Vermeersch as VP of Investor Relations and Corporate Communications". Liège....
- [3] Hyloris Pharmaceuticals S.A.. (6/17/20). "Press Release: Hyloris Pharmaceuticals Launches Its Initial Public Offering on Euronext Brussels [Not for US, AU, CA, CH, IL, JP or ZA]". Liège....
- [4] Hyloris Pharmaceuticals S.A.. (5/26/20). "Press Release: Hyloris Appoints Patrick Jeanmart as Chief Financial Officer". Liège....
- [5] Hyloris Pharmaceuticals S.A.. (4/30/20). "Press Release: Hyloris Pharmaceuticals Successfully Raises €15 Million in Funding Round". Liège....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top